Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03361748 · OUTCOME

Cmax

Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma · Source last updated 2025-05-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
transgene copies/ug of genomic DNA
Interval / dispersion
Standard Deviation
Time frame
From first dose to the end of follow up (Approximately 5 years)

What was measured

Cmax is defined as the maximum transgene level at Tmax Tmax: The time of maximum observed transgene level, obtained directly from the observed transgene level - time.

Analysis population: PK Evaluable Population

Groups in this outcome

BB2121

BB2121

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
BB2121136

Reported measurements

Total

Analysis denominator · Participants

GroupSource count
BB2121136
Values in transgene copies/ug of genomic DNA · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
BB2121388150.65372280.64Not reportedNot reportedNot reported
450x10^6 cells

Analysis denominator · Participants

GroupSource count
BB212163
Values in transgene copies/ug of genomic DNA · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
BB2121449826.92375293.18Not reportedNot reportedNot reported
300x10^6 cells

Analysis denominator · Participants

GroupSource count
BB212169
Values in transgene copies/ug of genomic DNA · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
BB2121335916.20369546.39Not reportedNot reportedNot reported
150x10^6 cells

Analysis denominator · Participants

GroupSource count
BB21214
Values in transgene copies/ug of genomic DNA · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
BB2121317793.50284926.30Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        372280.64
        value
        388150.65
    denoms
    1. counts
      1. group Id
        OG000
        value
        136
      units
      Participants
    title
    Total
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        375293.18
        value
        449826.92
    denoms
    1. counts
      1. group Id
        OG000
        value
        63
      units
      Participants
    title
    450x10^6 cells
  3. categories
    1. measurements
      1. group Id
        OG000
        spread
        369546.39
        value
        335916.20
    denoms
    1. counts
      1. group Id
        OG000
        value
        69
      units
      Participants
    title
    300x10^6 cells
  4. categories
    1. measurements
      1. group Id
        OG000
        spread
        284926.30
        value
        317793.50
    denoms
    1. counts
      1. group Id
        OG000
        value
        4
      units
      Participants
    title
    150x10^6 cells
denoms
  1. counts
    1. group Id
      OG000
      value
      136
    units
    Participants
description
Cmax is defined as the maximum transgene level at Tmax Tmax: The time of maximum observed transgene level, obtained directly from the observed transgene level - time.
dispersion Type
Standard Deviation
groups
  1. description
    BB2121
    id
    OG000
    title
    BB2121
param Type
MEAN
population Description
PK Evaluable Population
reporting Status
POSTED
time Frame
From first dose to the end of follow up (Approximately 5 years)
title
Cmax
type
SECONDARY
unit Of Measure
transgene copies/ug of genomic DNA

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice